New Gastrointestinal Liner Shows Promise in Controlling Type 2 Diabetes
Thursday September 18, 2008
Results of a clinical trial presented at the First World Congress on Interventional Therapies for Type 2 Diabetes on September 16th showed promise in improving blood glucose levels and weight loss.
The unique procedure mimics the way gastric bypass surgery works, without using surgical methods.
The EndoBarrier™ Gastrointestinal Liner, is a non-invasive, removable device which is inserted orally and ultimately positioned in the small intestine, forming a barrier which blocks absorption of food. When the liner is in place, it has an immediate effect, by producing weight loss and possible resolution of type 2 diabetes. Clinical trials support these findings.
Read the press release here... Photo of human small intestine courtesy of Stockbyte/Getty Images
Comments
It will be years, if ever, before this is available to the public. I’m skeptical about the device, but always hopeful.
-Steve
It may block absorption of food, but what about nutrients–would those be affected? Would it interfere with digestion and elemination? How would it stay in place and not go all the way through?